Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 35 full-time employees. The company went IPO on 2016-06-03. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Follow-Up Questions
Sensus Healthcare Inc (SRTS)의 PER은 얼마입니까?
Sensus Healthcare Inc의 PER은 7.9764입니다
Sensus Healthcare Inc의 CEO는 누구입니까?
Mr. Joseph Sardano은 2010부터 회사에 합류한 Sensus Healthcare Inc의 Chairman of the Board입니다.
SRTS 주식의 가격 성능은 어떻습니까?
SRTS의 현재 가격은 $3.46이며, 전 거래일에 decreased 0.54% 하였습니다.
Sensus Healthcare Inc의 주요 사업 주제나 업종은 무엇입니까?
Sensus Healthcare Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Sensus Healthcare Inc의 시가총액은 얼마입니까?
Sensus Healthcare Inc의 현재 시가총액은 $56.8M입니다
Sensus Healthcare Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 6명의 분석가가 Sensus Healthcare Inc에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 8명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다